Oscar Health, Inc.
OSCR
$17.97
-$0.19-1.05%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.26B | 10.71B | 10.06B | 9.16B | 8.20B |
| Total Other Revenue | 24.44M | 20.54M | 19.27M | 20.58M | 21.49M |
| Total Revenue | 11.29B | 10.73B | 10.08B | 9.18B | 8.22B |
| Cost of Revenue | 9.46B | 8.88B | 8.04B | 7.33B | 6.47B |
| Gross Profit | 1.82B | 1.84B | 2.04B | 1.84B | 1.74B |
| SG&A Expenses | 2.00B | 1.94B | 1.84B | 1.76B | 1.65B |
| Depreciation & Amortization | 30.25M | 30.43M | 31.06M | 32.15M | 30.65M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.50B | 10.86B | 9.91B | 9.12B | 8.16B |
| Operating Income | -210.34M | -129.47M | 168.83M | 57.27M | 59.52M |
| Income Before Tax | -238.31M | -151.33M | 143.16M | 33.43M | 36.47M |
| Income Tax Expenses | 5.45M | 9.33M | 19.01M | 7.31M | 6.90M |
| Earnings from Continuing Operations | -243.75 | -160.66 | 124.15 | 26.12 | 29.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -333.00K | -575.00K | -810.00K | -689.00K | -619.00K |
| Net Income | -244.09M | -161.23M | 123.34M | 25.43M | 28.95M |
| EBIT | -210.34M | -129.47M | 168.83M | 57.27M | 59.52M |
| EBITDA | -180.10M | -99.03M | 199.89M | 89.41M | 90.17M |
| EPS Basic | -0.95 | -0.64 | 0.49 | 0.16 | 0.12 |
| Normalized Basic EPS | -0.58 | -0.38 | 0.35 | 0.12 | 0.09 |
| EPS Diluted | -1.19 | -0.88 | 0.21 | -0.08 | -0.06 |
| Normalized Diluted EPS | -0.71 | -0.51 | 0.19 | -0.02 | -0.05 |
| Average Basic Shares Outstanding | 1.01B | 998.13M | 981.27M | 961.43M | 940.30M |
| Average Diluted Shares Outstanding | 1.07B | 1.05B | 1.10B | 1.09B | 1.07B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |